Stem cell bill may be stalled in US SenateBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7511.255-a (Published 28 July 2005) Cite this as: BMJ 2005;331:255
- Janice Hopkins Tanne
- New York
Action on the bill to increase funding for embryonic stem cell research and to expand the number of embryonic stem cell lines available seemed to have stalled with only days left before the US Senate began its August vacation. The House of Representatives passed the bill in May challenging George Bush, who has limited federal funding to the 22 stem cell lines in existence on 9 August 2001. Scientists say that few of these lines remain and that all may be contaminated (BMJ 2005;330:214).
The bill, passed by the House of Representatives and awaiting a Senate vote before, normally, being signed into law by the president, would fund research on thousands of frozen embryos left over after fertility treatment and voluntarily donated by the couples (BMJ 2005;330:1285).
President Bush has said that he would …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial